News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ROBERTSON MICHELLE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/27/2023 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on GERON CORP|
Txns:
| Granted 1,350,000 options to buy
@ $2.17, valued at
$2.9M
|
|
| 09/27/2023 |
3
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 3 on GERON CORP |
| 05/16/2023 |
4
| ROBERTSON MICHELLE (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 62,500 options to buy
@ $0.42, valued at
$26.3k
|
|
| 05/15/2023 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 949 shares
@ $9.872, valued at
$9.4k
|
|
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/06/2023 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 31,500 shares
@ $0
Sold 184 shares
@ $8.89, valued at
$1.6k
Granted 94,500 options to buy
@ $8.72, valued at
$824k
|
|
| 01/12/2023 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 1,752 shares
@ $8.1601, valued at
$14.3k
|
|
| 12/20/2022 |
4/A
| ROBERTSON MICHELLE (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 62,500 options to buy
@ $1.07, valued at
$66.9k
|
|
| 12/06/2022 |
4
| ROBERTSON MICHELLE (EVP, CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 193 shares
@ $10.23, valued at
$2k
|
|
| 09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2022 |
4
| ROBERTSON MICHELLE (CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Sold 1,744 shares
@ $25.7, valued at
$44.8k
|
|
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| ROBERTSON MICHELLE (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 63,493 options to buy
@ $3.11, valued at
$197.5k
|
|
| 11/17/2021 |
3
| ROBERTSON MICHELLE (Director) has filed a Form 3 on Verastem, Inc. |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2020 |
4
| ROBERTSON MICHELLE (CFO) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 120,000 options to buy
@ $30.65, valued at
$3.7M
|
|
| 01/10/2020 |
3
| ROBERTSON MICHELLE (CFO) has filed a Form 3 on Editas Medicine, Inc. |
| 10/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2019 |
4
| ROBERTSON MICHELLE (CFO) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 4,725 shares
@ $0 |
|
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|